A Randomized Phase II study of Reolysin in Patients with Previously Treated Advanced or Metatstatic Non Small Cell Lung Cancer (NSCLC) receiving Standard Salvage Chemotherapy – Canadian Cancer Trials Group IND 211

Autor:	Rafal Wierzbicki, Grzegorz Korpanty, Nevin Murray, Bruce Keith, Sara Kuruvilla, Dongsheng Tu, Scott A. Laurie, Normand Blais, Richard Gregg, Joana Sederias, Donald Morris, Garth Nicholas, Penelope A. Bradbury, John R. Goffin, Asif Ahmed, Glenwood D. Goss, Frances A. Shepherd, Christopher W. Lee, Mustapha Tehfe, Lesley Seymour
Rok vydání:	2016
Předmět:	0301 basic medicine Oncology Cancer Research medicine.medical_specialty business.industry medicine.medical_treatment Salvage treatment Phases of clinical research Cancer non-small cell lung cancer (NSCLC) Immunotherapy medicine.disease respiratory tract diseases Surgery Targeted therapy 03 medical and health sciences 030104 developmental biology 0302 clinical medicine 030220 oncology & carcinogenesis Internal medicine Reolysin medicine In patient business
Zdroj:	Journal of Clinical Oncology. 34:e20512-e20512
ISSN:	1527-7755 0732-183X
Popis:	e20512Background: Despite advances associated with the use of targeted therapy, cytotoxic chemotherapy and immunotherapy the treatment of advanced NSCLC remains challenging. In this study we evalua...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::43e6a34d52a432333aed7c50431d1b94 https://doi.org/10.1200/jco.2016.34.15_suppl.e20512 Zobrazit plný text záznamu